CVR: 28310102
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity amounted to DKK 2,505,002.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med handel, industri, håndværk og finansiering og anden i forbindelse hermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 2.5 mio. | 183 t. | 3.7 mio. | 2.5 mio. | 0 | |
| 2024 | 2.9 mio. | 1.7 mio. | 3.4 mio. | 2.3 mio. | 1 | |
| 2023 | 3.1 mio. | 900 t. | 4.3 mio. | 3.5 mio. | 1 | |
| 2022 | 2.4 mio. | 586 t. | 5.4 mio. | 4.6 mio. | 1 | |
| 2021 | 3.7 mio. | 1.9 mio. | 5 mio. | 4.1 mio. | 1 | |
| 2020 | 1.6 mio. | 500 t. | 2.4 mio. | 2.2 mio. | 1 | |
| 2019 | 1.5 mio. | 257 t. | 1.8 mio. | 1.7 mio. | 1 | |
| 2018 | 1 mio. | -467 t. | 1.5 mio. | 1.4 mio. | 1 | |
| 2017 | 968 t. | 103 t. | 2.1 mio. | 1.9 mio. | 1 | |
| 2016 | 747 t. | 33 t. | 947 t. | 767 t. | 1 | |
| 2015 | 438 t. | -253 t. | 839 t. | 734 t. | - | |
| 2014 | 279 t. | -250 t. | 1.1 mio. | 987 t. | - | |
| 2013 | 106 t. | -977 t. | 607 t. | -263 t. | - | |
| 2012 | 384 t. | 8 t. | 1.2 mio. | 714 t. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 172 companies in Fremstilling af andre fødevarer i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
BIODANE PHARMA A/S has published its annual report for 2025. Gross profit came to DKK 2,534,166, and the net result was DKK 182,862.
BIODANE PHARMA A/S has published its annual report for 2024. Gross profit came to DKK 2,886,145, and the net result was DKK 1,651,356.
BIODANE PHARMA A/S has published its annual report for 2023. Gross profit came to DKK 3,070,739, and the net result was DKK 900,246.
As of May 15, 2024, Peter Gæmelke has joined the board of directors of BIODANE PHARMA A/S.
As of May 15, 2024, Flemming Torben Heden Knudsen has joined the board of directors of BIODANE PHARMA A/S.
As of May 15, 2024, Lars Jørgen Larsen has left the board of directors of BIODANE PHARMA A/S.
As of March 4, 2024, Michael Prasanjit Baruah has left the board of directors of BIODANE PHARMA A/S.
BIODANE PHARMA A/S has published its annual report for 2022. Gross profit came to DKK 2,371,672, and the net result was DKK 586,354.
BIODANE PHARMA A/S has published its annual report for 2021. Gross profit came to DKK 3,701,319, and the net result was DKK 1,897,649.
BIODANE PHARMA A/S has published its annual report for 2020. Gross profit came to DKK 1,628,847, and the net result was DKK 499,535.
BIODANE PHARMA A/S has published its annual report for 2019. Gross profit came to DKK 1,508,453, and the net result was DKK 256,752.
BIODANE PHARMA A/S has published its annual report for 2018. Gross profit came to DKK 1,010,830, and the net result was DKK -467,077.
BIODANE PHARMA A/S has published its annual report for 2017. Gross profit came to DKK 967,640, and the net result was DKK 102,788.
BIODANE PHARMA A/S has published its annual report for 2016. Gross profit came to DKK 747,313, and the net result was DKK 32,975.
BIODANE PHARMA A/S has published its annual report for 2015. Gross profit came to DKK 437,995, and the net result was DKK -253,036.
BIODANE PHARMA A/S has published its annual report for 2014. Gross profit came to DKK 278,919, and the net result was DKK -250,379.
BIODANE PHARMA A/S has published its annual report for 2013. Gross profit came to DKK 106,251, and the net result was DKK -976,558.
BIODANE PHARMA A/S has published its annual report for 2012. Gross profit came to DKK 384,418, and the net result was DKK 8,087.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of BIODANE PHARMA A/S.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of BIODANE PHARMA A/S.
As of October 6, 2011, Michael Prasanjit Baruah has joined the board of directors of BIODANE PHARMA A/S.
As of October 6, 2011, Rasmus Juhl Rasmussen has joined the board of directors of BIODANE PHARMA A/S.
As of October 6, 2011, Lars Jørgen Larsen has joined the board of directors of BIODANE PHARMA A/S.
As of October 6, 2011, Gunner Kreutzer Jakobsen has joined the board of directors of BIODANE PHARMA A/S.
As of October 6, 2011, Gunner Kreutzer Jakobsen is registered as adm. dir. of BIODANE PHARMA A/S.
As of January 1, 2007, BIODAN A/S is registered as an owner of BIODANE PHARMA A/S with an ownership share of 100%.
As of December 29, 2004, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of BIODANE PHARMA A/S.
BIODANE PHARMA A/S was founded on December 29, 2004.
companydata.dk